ea0034oc6.1 | Clinical | SFEBES2014
Chapman Matthew
, Argese Nicola
, Mani Dhanasekaran
, Dabhi Vijay
, Boot Christopher
, Crowley Rachel
, Stewart Paul
, Tomlinson Jeremy
23% of the UK population are prescribed glucocorticoid (GC) therapy and their adverse effects contribute to a significant health burden. Suppression of endogenous GC secretion is a recognized complication of therapy, but the magnitude of the problem, together with its clinical consequences have not been determined. We conducted a retrospective study across all specialties in a large secondarytertiary care center identifying 2782 patients who underwent 3666 250 _...